Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of APOBEC3B mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of APOBEC3B mRNA | decreases expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of APOBEC3B mRNA | increases expression | 16474171
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of APOBEC3B mRNA | decreases expression | 20106945
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of APOBEC3B mRNA | increases expression | 19194470
|
C014347 |
decitabine |
pyrimidin-2-one beta-ribofuranoside inhibits the reaction [APOBEC3B protein results in decreased amination of decitabine] | decreases amination|decreases reaction | 18398609
|
C014347 |
decitabine |
[pyrimidin-2-one beta-ribofuranoside results in decreased activity of APOBEC3B protein] which results in increased susceptibility to decitabine | decreases activity|increases response to substance | 18398609
|
D004958 |
Estradiol |
Estradiol results in increased expression of APOBEC3B mRNA | increases expression | 16474171 19139166 20106945
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] affects the expression of APOBEC3B mRNA | affects cotreatment|affects expression | 17404688
|
D019833 |
Genistein |
Genistein results in increased expression of APOBEC3B mRNA | increases expression | 16474171
|
D007529 |
Isoflavones |
Isoflavones results in decreased expression of APOBEC3B mRNA | decreases expression | 17374662
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of APOBEC3B mRNA | increases expression | 16474171
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] affects the expression of APOBEC3B mRNA | affects cotreatment|affects expression | 17404688
|
C009131 |
pyrimidin-2-one beta-ribofuranoside |
pyrimidin-2-one beta-ribofuranoside inhibits the reaction [APOBEC3B protein results in decreased amination of decitabine] | decreases amination|decreases reaction | 18398609
|
C009131 |
pyrimidin-2-one beta-ribofuranoside |
[pyrimidin-2-one beta-ribofuranoside results in decreased activity of APOBEC3B protein] which results in increased susceptibility to decitabine | decreases activity|increases response to substance | 18398609
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.24 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.24 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
7.24 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.71 | 6695378 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.81 | 17569567 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.97 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.51 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.40 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.01 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.01 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
3.01 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.01 | 17261762 17289903 19861407 12948864 16675129 17018787 14630087 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
3.01 | 16541309 16873071 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.01 | 17614352 15562024 16175315 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.62 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.15 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
3.15 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.14 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.77 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.77 | 19215824 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.01 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
8.01 | 17689850 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.71 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.71 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
16.71 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.71 | 18566989 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.00 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.95 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.95 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.76 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
3.76 | 17116718 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
3.76 | 15531428 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.81 | 16140633 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.51 | 16647724 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.51 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.63 | 17187935 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.91 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.29 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.74 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.74 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.74 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.87 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.43 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.43 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.96 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.28 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.33 | 16598420 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.56 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.71 | 20471113 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.21 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
4.52 | 16200630 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
11.01 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
11.01 | 17290160 14716179 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.13 | 10903974 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.54 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.27 | 17581917 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.65 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.67 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.67 | 16627594 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.14 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.14 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.58 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.58 | 15610895 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.69 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.69 | 17468513 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.11 | 18454857 17236224 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.39 | 18460780 18704418 17679729 19387464 19010910 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.64 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.59 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
2.59 | 17823541 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.08 | 20195826 21137059 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
3.66 | 1423854 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20135361 20464547 18816296 18520028 6695378 17053015 18569708 20869020 20064080 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.49 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.42 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
10.42 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.42 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.66 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
4.14 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
pyrimidin-2-one beta-ribofuranoside |
4.14 | 16505122 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.42 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.44 | 18608210 16882708 19010910 19157545 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.90 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.80 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.80 | 17141266 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.27 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.27 | 19116145 17925555 19470736 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.89 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
17.24 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.24 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
17.24 | 16427766 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.81 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.81 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.20 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.14 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.58 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.58 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.58 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.58 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.80 | 19294695 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.43 | 16702228 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.50 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.10 | 10548101 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.87 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.92 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.92 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.90 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
1.90 | 17374662 17571952 16365062 17219775 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
1.90 | 15721890 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.94 | 10548101 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.52 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.89 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.41 | 19755658 10029692 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.43 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.48 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.48 | 19037991 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.14 | 16684133 16045194 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.41 | 17967635 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.86 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.26 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.26 | 17616700 19087683 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.18 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.09 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |